StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Down 5.5 % Shares of NASDAQ:MBRX opened at $0.56 on Friday. The company has a market cap of $16.54 million, a […]
More Stories
Bayhorse Silver (CVE:BHS) Shares Up 33.3% – Still a Buy?
Bayhorse Silver Inc. (CVE:BHS – Get Free Report) shares shot up 33.3% during mid-day trading on Saturday . The company...
ARM (NASDAQ:ARM) Trading Down 2% – Time to Sell?
Arm Holdings plc (NASDAQ:ARM – Get Free Report) shares were down 2% during trading on Thursday . The stock traded...
Uber Technologies (NYSE:UBER) Stock Price Down 1% – What’s Next?
Shares of Uber Technologies, Inc. (NYSE:UBER – Get Free Report) dropped 1% during mid-day trading on Thursday . The stock...
Head-To-Head Contrast: Seabridge Gold (NYSE:SA) vs. SilverCrest Metals (NYSE:SILV)
SilverCrest Metals (NYSE:SILV – Get Free Report) and Seabridge Gold (NYSE:SA – Get Free Report) are both small-cap basic materials...
Congress Passes Revised Funding Plan, Averting Government Shutdown
By Joseph Lord and Arjun Singh WASHINGTON—Both chambers of Congress on Dec. 21 passed a last-minute funding package that would...
GoDaddy (NYSE:GDDY) Trading Up 1.2% – What’s Next?
GoDaddy Inc. (NYSE:GDDY – Get Free Report) was up 1.2% on Thursday . The stock traded as high as $205.05...